1. Business

Capillary and Venous Blood Sampling Devices Market 2023 Industry Size, Shares, Segment and Forecast up to 2035

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.
Research Nester’s recent market research analysis on Capillary and Venous Blood Sampling Devices Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global capillary and venous blood sampling devices market in terms of market segmentation by product, device, application, end-user, and by region.
 
Increasing Prevalence of Diabetes Worldwide to Drive Growth of Global Capillary and Venous Blood Sampling Devices Market
 
The increasing prevalence of diabetes is expected to have a positive impact on the market for capillary and venous blood sampling devices. Population with diabetes must monitor their blood sugar levels regularly to manage their condition and prevent complications. For instance, as per the WHO statistics, a total of 537 million individuals (20-79 years old) worldwide have diabetes. It is anticipated that by 2030, there will be 643 million diabetics worldwide, and by 2045, there will be 783 million. Adults with diabetes make up three out of four of the population in low- and middle-income nations.
 
 
Capillary and venous blood sampling equipment are extensively used in hospitals, clinics, and other healthcare settings for blood collection. These technologies enable healthcare providers to rapidly and efficiently collect blood samples, lowering the risk of complications and ensuring the safety and accuracy of the blood samples.
 
Some of the major growth factors and challenges that are associated with the growth of the global capillary and venous blood sampling devices market are:
 
Growth Drivers:
 
  • Rise in demand for blood collection and transfusions
  • Increasing demand for apheresis
Challenges:
 
Stringent regulatory approval and product recall associated with capillary and venous blood sampling devices, and limited access to healthcare in low and middle-income countries are some of the major factors anticipated to hamper the growth of the global capillary and venous blood sampling devices market.
 
 
By product, the global capillary and venous blood sampling devices market is segmented into capillary blood collection devices and venous blood collection devices. The venous blood collection devices segment is to garner the highest CAGR of 7.6% over the forecast period. This can be attributed due to the rising preference in clinical laboratories for the detection of major chronic diseases as no repeated blood collection process is required. Venous blood collection is the procedure often done in routine laboratory tests due to the benefits of these venous blood collection devices as they offer the exact filling volume. It has fueled the growth of capillary and venous blood sampling devices over the forthcoming years. Moreover, the main venous blood sampling devices are tubes and vacutainer systems used for cancer, HIV/AIDS and other blood testing which are fueling the expansion of the venous blood collection devices market.
 
By region, the North American capillary and venous blood sampling devices market are to generate the highest revenue of USD 5,040.2 million by the end of 2035. The demand for capillary and venous blood sample devices is increasing along with the surging number of people suffering from communicable and non-communicable diseases. For instance, heart disease is the main cause of death for both sexes and the majority of American populations. Demand for blood testing for these illnesses will increase since almost 20% of all fatalities from coronary artery disease in 2020 will be in persons under the age of 65.
 
This report also provides the existing competitive scenario of some of the key players of the global capillary and venous blood sampling devices market which include company profiling of Abacus ALS, Medtronic, Bio-Rad Laboratories, Inc., B. Braun Melsungen AG, Thermo Fisher Scientific, Inc., Medtronic Plc, Merck KGaA, Bio-Rad Laboratories, Inc., Ypsomed Holding AG, Owen Mumford Ltd., Greiner Bio-One International GmbH, SB-KAWASUMI LABORATORIES, INC., Terumo Corporation and others.
 
 
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, and investment, etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
 
Contact for more Info:
 
AJ Daniel
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe